Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S4 from Pembrolizumab with Chemotherapy for Patients with Recurrent or Metastatic Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma: A Prospective Phase ll Study
  1. Home
  2. Publications
  3. Supplementary Figure S4 from Pembrolizumab with Chemotherapy for Patients with Recurrent or Metastatic Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma: A Prospective Phase ll Study

Supplementary Figure S4 from Pembrolizumab with Chemotherapy for Patients with Recurrent or Metastatic Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma: A Prospective Phase ll Study

Authors:
  • YQYuquan Qian
    Yuquan Qian
  • LTLe Tang
    Le Tang
  • JYJiarui Yao
    Jiarui Yao
  • YZYiming Zhu
    Yiming Zhu
  • YZYe Zhang
    Ye Zhang
  • HLHaizhen Lu
    Haizhen Lu
  • WLWeihua Li
    Weihua Li
  • CAChangming An
    Changming An
  • LGLin Gui
    Lin Gui

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.32712535
Abstract
Univariate association analysis for progression-free survival
Keywords
  • CELL CARCINOMA
  • SUPPLEMENTARY FIGURE
  • METASTATIC NASAL
  • NASAL CAVITY
  • PARANASAL SINUS
  • SINUS SQUAMOUS
  • SQUAMOUS CELL
  • PROSPECTIVE PHASE
  • STUDY UNIVARIATE
  • UNIVARIATE ASSOCIATION
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.